Share ownership AstraZeneca PLC

AZN

GB0009895292

Pharmaceuticals

Delayed London S.E. Other stock markets 13:32:36 16/01/2026 GMT			5-day change	1st Jan Change
14,126.00 ^GBp	+0.71%		-0.62%	+2.45%

10:38am	ASTRAZENECA : Buy rating from UBS	ZD
10:36am	ASTRAZENECA : Deutsche Bank gives a Sell rating	ZD

Share class: AstraZeneca PLC

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	1,550,581,134	1,498,095,796 ( 96.62 %)	0	96.62 %

Major shareholders: AstraZeneca PLC

Name	Equities	%	Valuation
Wellington Management Co. LLP 4.199 %	65,120,892	4.199 %	12 079 M GBp
BlackRock Investment Management (UK) Ltd. 3.599 %	55,810,709	3.599 %	10 352 M GBp
Capital Research & Management Co. (World Investors) 3.411 %	52,902,092	3.411 %	9 812 M GBp
Investor AB (Investment Company) 3.327 %	51,587,810	3.327 %	9 569 M GBp
The Vanguard Group, Inc. 2.644 %	41,001,413	2.644 %	7 605 M GBp
Norges Bank Investment Management 2.085 %	32,331,000	2.085 %	5 997 M GBp
BlackRock Fund Advisors 1.24 %	19,225,203	1.24 %	3 566 M GBp
Goldman Sachs Asset Management LP 1.112 %	17,245,000	1.112 %	3 199 M GBp
SSgA Funds Management, Inc. 1.092 %	16,928,000	1.092 %	3 140 M GBp
Legal & General Investment Management Ltd. 1.079 %	16,738,000	1.079 %	3 105 M GBp
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Name	Equities	%	Valuation
T. Rowe Price International Ltd. 1.584 %	49,124,476	1.584 %	4 516 M GBp
PRIMECAP Management Co. 1.285 %	39,857,971	1.285 %	3 664 M GBp
Merrill Lynch International 1.052 %	32,633,139	1.052 %	3 000 M GBp
Wellington Trust Co., NA 1.041 %	32,299,561	1.041 %	2 969 M GBp
Capital Research & Management Co. (International Investors) 0.8078 %	25,052,520	0.8078 %	2 303 M GBp
Fidelity Management & Research Co. LLC 0.699 %	21,679,065	0.699 %	1 993 M GBp
Fisher Asset Management LLC 0.6823 %	21,162,724	0.6823 %	1 945 M GBp
Fiduciary Trust Company International 0.6351 %	19,697,596	0.6351 %	1 811 M GBp
Sanders Capital LLC 0.4533 %	14,058,682	0.4533 %	1 292 M GBp
Goldman Sachs Wealth Services LP 0.4408 %	13,671,749	0.4408 %	1 257 M GBp
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Name	Equities	%	Valuation
Caixa DTVM SA 0.002216 %	206,233	0.002216 %	3 M GBp

Breakdown by shareholder type

Institutional	79.63%
Other	5.07%
Swedbank AB	0.28%
Governments	0.07%
State Street Corp.	0.06%
SEI Investments Co.	0.06%
Phoenix Financial Ltd.	0.05%
ABC arbitrage SA	0.04%
Silvercrest Asset Management Group, Inc.	0.02%
Individuals	0.02%
Avolta AG	0.01%
Sumitomo Mitsui Trust Group, Inc.	0.01%
Manulife Financial Corp.	0.01%
Principal Financial Group, Inc.	0.01%
Peapack-Gladstone Financial Corp.	0.01%
Cullen/Frost Bankers, Inc.	0.01%
Migdal Insurance & Financial Holdings Ltd.	0.01%
Svenska Handelsbanken AB	0.01%
Wärtsilä Oyj Abp	0.01%
Unknown	14.61%

Based on 1000 largest holdings

Geographical origin of shareholders

United States	46.37%
United Kingdom	20.61%
Sweden	4.83%
Norway	2.36%
Canada	1.55%
Luxembourg	1.22%
Switzerland	1.08%
France	0.89%
Germany	0.88%
Netherlands	0.71%
Japan	0.7%
Australia	0.56%
Denmark	0.44%
Singapore	0.42%
Belgium	0.34%
Bahamas	0.34%
Ireland	0.29%
South Korea	0.28%
Spain	0.23%
Italy	0.21%
Hong Kong	0.18%
Finland	0.15%
Austria	0.13%
Czech Republic	0.09%
Israel	0.08%
Taiwan	0.06%
Bermuda	0.06%
South Africa	0.05%
Kazakhstan	0.04%
China	0.04%
United Arab Emirates	0.03%
Thailand	0.02%
Malaysia	0.02%
Individuals	0.02%
Mexico	0.02%
Slovenia	0.02%
Greece	0.01%
Liechtenstein	0.01%
Kuwait	0.01%
Cyprus	0.01%
New Zealand	0.01%
Brazil	0.01%

Based on 1000 largest holdings

AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (94.2%). Net sales break down by treatment area between oncology (39.8%), cardiovascular, renal and metabolic diseases (24.4%), respiratory and autoimmune diseases (14.6%), and other (21.2%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (5.8%). Net sales are distributed geographically as follows: the United Kingdom (8.8%), Europe (21.6%), the United States (40.3%), Americas (5.9%) and Africa/Asia/Australia (23.4%).

Employees

94,300

Sector

Pharmaceuticals

Calendar

02-10 - Q4 2025 Earnings Release

More about the company